A nem kissejtes tudorak terapias lehetosegei - A kemoterapia jelenlegi szemlelete

Translated title of the contribution: Therapeutic options of non small cell lung cancer - Present aspects of chemotherapy

Research output: Contribution to journalArticle

Abstract

There is a definite place of chemotherapy, radiotherapy, surgical resection as well as supportive care in the treatment of non small cell lung cancer. The author summarizes the therapeutic options of non small cell lung cancer according to literature results and also his own experiences. In the recent years advances in the chemotherapy of non small cell lung cancer could be observed. Large international studies are ongoing to evaluate the effectiveness of platinum based adjuvant cytostatic treatment in patients with early stage non small cell lung cancer. Patients with ipsilateral mediastinal lymph node involvement (N2) can be treated with chemotherapy as well as with surgical resection and postoperative irradiation. In the locally advanced stage the combination of chemotherapy and radiotherapy should be applied. The use of new cytostatic drugs (taxanes, gemcitabine, vinorelbine, topoisomerase inhibitors) combined with platinum derivates can improve the therapeutic response rate and also expected survival. The combination of new drugs with each other or the use of three drugs are under investigation. However, it is important to emphasize the importance of optimum supportive care in all stages of the disease in order to keep the quality of life of the patients at the highest possible level.

Original languageHungarian
Pages (from-to)664-669
Number of pages6
JournalLege Artis Medicinae
Volume9
Issue number9
Publication statusPublished - 1999

Fingerprint

Non-Small Cell Lung Carcinoma
Drug Therapy
Cytostatic Agents
gemcitabine
Platinum
Radiotherapy
Topoisomerase Inhibitors
Taxoids
Drug Combinations
Therapeutics
Combination Drug Therapy
Lymph Nodes
Quality of Life
Survival
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A nem kissejtes tudorak terapias lehetosegei - A kemoterapia jelenlegi szemlelete. / Ostoros, G.

In: Lege Artis Medicinae, Vol. 9, No. 9, 1999, p. 664-669.

Research output: Contribution to journalArticle

@article{e7b7c33e1be0485b96acdd90ab98d66c,
title = "A nem kissejtes tudorak terapias lehetosegei - A kemoterapia jelenlegi szemlelete",
abstract = "There is a definite place of chemotherapy, radiotherapy, surgical resection as well as supportive care in the treatment of non small cell lung cancer. The author summarizes the therapeutic options of non small cell lung cancer according to literature results and also his own experiences. In the recent years advances in the chemotherapy of non small cell lung cancer could be observed. Large international studies are ongoing to evaluate the effectiveness of platinum based adjuvant cytostatic treatment in patients with early stage non small cell lung cancer. Patients with ipsilateral mediastinal lymph node involvement (N2) can be treated with chemotherapy as well as with surgical resection and postoperative irradiation. In the locally advanced stage the combination of chemotherapy and radiotherapy should be applied. The use of new cytostatic drugs (taxanes, gemcitabine, vinorelbine, topoisomerase inhibitors) combined with platinum derivates can improve the therapeutic response rate and also expected survival. The combination of new drugs with each other or the use of three drugs are under investigation. However, it is important to emphasize the importance of optimum supportive care in all stages of the disease in order to keep the quality of life of the patients at the highest possible level.",
keywords = "Complex treatment, Follow up, Non small cell lung cancer, Quality of life",
author = "G. Ostoros",
year = "1999",
language = "Hungarian",
volume = "9",
pages = "664--669",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "9",

}

TY - JOUR

T1 - A nem kissejtes tudorak terapias lehetosegei - A kemoterapia jelenlegi szemlelete

AU - Ostoros, G.

PY - 1999

Y1 - 1999

N2 - There is a definite place of chemotherapy, radiotherapy, surgical resection as well as supportive care in the treatment of non small cell lung cancer. The author summarizes the therapeutic options of non small cell lung cancer according to literature results and also his own experiences. In the recent years advances in the chemotherapy of non small cell lung cancer could be observed. Large international studies are ongoing to evaluate the effectiveness of platinum based adjuvant cytostatic treatment in patients with early stage non small cell lung cancer. Patients with ipsilateral mediastinal lymph node involvement (N2) can be treated with chemotherapy as well as with surgical resection and postoperative irradiation. In the locally advanced stage the combination of chemotherapy and radiotherapy should be applied. The use of new cytostatic drugs (taxanes, gemcitabine, vinorelbine, topoisomerase inhibitors) combined with platinum derivates can improve the therapeutic response rate and also expected survival. The combination of new drugs with each other or the use of three drugs are under investigation. However, it is important to emphasize the importance of optimum supportive care in all stages of the disease in order to keep the quality of life of the patients at the highest possible level.

AB - There is a definite place of chemotherapy, radiotherapy, surgical resection as well as supportive care in the treatment of non small cell lung cancer. The author summarizes the therapeutic options of non small cell lung cancer according to literature results and also his own experiences. In the recent years advances in the chemotherapy of non small cell lung cancer could be observed. Large international studies are ongoing to evaluate the effectiveness of platinum based adjuvant cytostatic treatment in patients with early stage non small cell lung cancer. Patients with ipsilateral mediastinal lymph node involvement (N2) can be treated with chemotherapy as well as with surgical resection and postoperative irradiation. In the locally advanced stage the combination of chemotherapy and radiotherapy should be applied. The use of new cytostatic drugs (taxanes, gemcitabine, vinorelbine, topoisomerase inhibitors) combined with platinum derivates can improve the therapeutic response rate and also expected survival. The combination of new drugs with each other or the use of three drugs are under investigation. However, it is important to emphasize the importance of optimum supportive care in all stages of the disease in order to keep the quality of life of the patients at the highest possible level.

KW - Complex treatment

KW - Follow up

KW - Non small cell lung cancer

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=0032728033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032728033&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032728033

VL - 9

SP - 664

EP - 669

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 9

ER -